← Eichor
Study identifier: NCT06400043 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Dual-tasking Effect on Gait in Children With Developmental Coordination Disorder

Condition: Gait  ·  Sponsor: University Ghent

PhaseNA
Planned participants23
Who can joinAll sexes, 7 Years to 17 Years
Healthy volunteersNo

About this study

The aim of the study is to collect data in children with developmental coordination disorder (DCD) aged between 7 and 17 years for analyses of the gait pattern while walking at the Gait Real-time Analysis Interactive Lab (GRAIL) at the university hospital of Ghent. Children with DCD will be asked to take a motor test (M-ABC-2) as well as walk on the treadmill during a single session of approximately 3 hours. The following data will be collected on the GRAIL while subjects walk at different gait speeds: 3D kinematics, kinetics, and EMG. Additionally, 3D kinematics, kinetics, and EMG data will be collected when performing either a cognitive (Stroop Color and Word Test) or motor (requiring arm swing) dual-task while walking at comfortable walking speed..

This description comes directly from the study's public registry record.

Talk to the study team

Michelle Verhoeven  ·  +32 9 332 46 57  ·  michelle.verhoeven@ugent.be

Always discuss trial participation with your own doctor first.

Locations (2)

Ghent UniversityGhent, East-Flanders, BelgiumRecruiting
Ghent UniversityGhent, BelgiumRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06400043